GENAHEAD BIO
GenAhead Bio is a biotechnology company focusing on genome editing and nucleic acid delivery.
GENAHEAD BIO
Industry:
Biotechnology
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.genaheadbio.com
Status:
Closed
Technology used in webpage:
SPF Google Apps For Business GMO Internet DNS GMO Internet
Similar Organizations
GenePharma
GenePharma is a biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.genaheadbio.com
- Host name: www19.gmoserver.jp
- IP address: 133.130.64.128
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "GenAhead Bio"
Corporate Information | GenAhead Bio Inc.
Feb 1, 2018 Corporate Name: GenAhead Bio Inc. (“GenAhead Bio”) Foundation: February 1, 2018: Head Office: 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012 JapanSee details»
GenAhead Bio Company Profile 2024: Valuation, …
GenAhead Bio General Information Description. Operator of a biotechnology company intended to develop pharmaceutical drug discovery and development. The company is focused on genome editing and nucleic acid delivery to offer …See details»
GenAhead Bio - Crunchbase Company Profile & Funding
GenAhead Bio is a biotechnology company. GenAhead Bio is a biotechnology company focusing on genome editing and nucleic acid delivery.See details»
GENAHEAD BIO, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GENAHEAD BIO, INC. of FUJISAWA, KANAGAWA. Get the latest business insights from Dun & Bradstreet.See details»
GenAhead Bio Inc. (JP) - Life-Sciences-Europe.com
Feb 1, 2018 https://www.genaheadbio.com GenAhead Bio is a new spinout biotechnology company focused on genome editing and nucleic acid delivery. Our headquarters are located …See details»
GenAhead Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore GenAhead Bio, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
企業情報 | 株式会社GenAhead Bio | ジェナヘッドバイオ
会社概要代表者挨拶株式会社GenAhead Bio（ジェナヘッド バイオ）は遺伝子技術に基づくバイオテク企業として、2018年に神奈川県藤沢市の湘南ヘルスイノベーションパークに設立さ …See details»
株式会社GenAhead Bio | ジェナヘッドバイオ | 明日の …
GenAhead Bioは、 効率的なゲノム編集と独自の核酸デリバリー技術を 併せ持つベンチャーですSee details»
株式会社GenAhead Bio | InfoBase
株式会社GenAhead Bio. 会社概要 「CRISPR-SNIPER」というゲノム編集サービスを提供しています。独自の遺伝子技術を用いた創薬研究の支援や、病態モデル細胞の作製に役立つSNP変 …See details»
GenAhead Bio Inc. - BioCentury Company Profiles - BCIQ
GenAhead Bio Inc. - BioCentury Company Profiles for the biopharma industrySee details»
株式会社GenAhead Bioの会社情報と資金調達 | NIKKEI COMPASS
【nikkei compass】株式会社genahead bioは、ゲノム編集と核酸送達技術に基づく創薬支援・開発を行う企業。 開発を進めているゲノム編集技術『crispr ...See details»
Genome Editing Services | GenAhead Bio Inc.
Single Nucleotide Polymorphism (SNP) cell generation. In recent years, the relationship between diseases and genetic mutations has been well investigated through advances in genomic DNA …See details»
Takeda spinoff GenAhead Bio inks partnership with ERS Genomics …
Oct 10, 2018 Takeda biotech spinoff GenAhead Bio has inked a nonexclusive license deal to access ERS Genomics’ CRISPR/Cas9 patents for genome editing technology.. Ireland-based …See details»
Nucleic Acid Delivery | GenAhead Bio Inc.
The binding affinities of several anti-TfR Ab clones to epitopes A,B,B’, C, and D are shown in the table. Silencing activities were evaluated among various anti-TfR clone-conjugated anti-HPRT …See details»
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License …
Oct 9, 2018 GenAhead and ERS announced a non-exclusive license agreement to provide GenAhead with access to ERS' CRISPR/Cas9 genome editing technology patents.See details»
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License …
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License AgreementSee details»
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License …
Oct 9, 2018 GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with …See details»
株式会社GenAhead Bio - スピーダ スタートアップ情報 ...
独自の遺伝子技術を用いた創薬研究の支援。 病態モデル細胞の作製に役立つSNP変換、分化研究に役立つ分化マーカー標識を中心とするゲノム編集サービス「CRISPR-SNIPER」の提供。 …See details»
リプロセル、株式会社GenAhead Bioへの戦略的出資に関するお知 …
Apr 24, 2018 当社は本日、優れた遺伝子編集技術を保有するベンチャー企業である株式会社GenAhead Bioが実施する第三者割当増資を引き受け、同社へ出資することを決定いたしまし …See details»
GenAhead Bio：ERS GenomicsとCRISPR / Cas9技術基本特許にお …
Oct 9, 2018 ： //www.genaheadbio.com ＜ERSについて＞ ERS Genomicsは、Emmanuelle Charpentier博士が保有するCRISPR / Cas9技術の基本特許に幅広くアクセスできるように …See details»